Skip to main content
. 2022 Dec 28;13(6):2736–2746. doi: 10.1016/j.apsb.2022.12.018

Figure 2.

Figure 2

Labeling of metabolically engineered cell-surface glycoconjugates. (A) Working flowchart for engineering and detection. MDA-MB-231 cells were grown with 25 μmol/L Ac4ManNTz (1) for three days, washed with PBS and labeled with TCO-Biotin (250 μmol/L) for 1 h at 37 °C, followed by incubation with Streptavidin-Cy5 (20 μg/mL) for 20 min at rt. (B) The chemical structure of Ac4ManNTz (1) and Ac4ManNPh (3). (C, D) Confocal images showing the MDA-MB-231 cells pretreated by the Ac4ManNTz (1) could be specifically labeled on the cell surface (arrow) while the control group pretreated by the Ac4ManNPh (3) displayed barely visible fluorescent signal. Scale bar: 20 μm. (E) Flow cytometry of cells pretreated with Ac4ManNTz (1) and Ac4ManNPh (3). (F) Mean Cy5 fluorescence intensity of MDA-MB-231 cells extracted from (C, D). Data were presented as mean ± SEM (n = 3) and analyzed by Student's t-test (two-tailed), ∗∗∗P ≤ 0.001.